Details for Patent: 5,972,920

Summary for Patent: 5,972,920

Title:	Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
Abstract:	One or more formulations for treating psoriasis and other skin disorders characterized by redness, itching, flaking, scaling, and plaque-type growth. The formulation includes a carrier component, one or more active ingredient components, and a surfactant component. The carrier preferably includes an alcohol in substantially equal volume with isopropyl myristate. The active ingredient component preferably includes a superpotent or high-potency corticosteroid such as clobetasol propionate, an anti-flaking ingredient such as zinc pyrithione, or a combination of the two. It may also include an anti-fungal compound. The surfactant component preferably includes an alkyl sulfate such as sodium lauryl sulfate. The formulations made by applied topically either in spray form or as a direct-contact liquid.
Inventor(s):	Seidel; William E. (Scarborough, ME)
Assignee:	Dermalogix Partners, Inc. (Scarborough, ME)
Application Number:	09/022,995
Patent Claim Types: see list of patent claims	Use; Formulation; Compound; Composition;

Drugs Protected by US Patent 5,972,920

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate